Axcelis Announces Participation At 19th Annual Needham Growth Conference
Get Alerts ACLS Hot Sheet
Join SI Premium – FREE
BEVERLY, Mass., Dec. 13, 2016 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the 19th Annual Needham Growth Conference. The conference is scheduled for January 10-12th at the Lotte New York Palace Hotel.
Mary Puma, president and CEO, Kevin Brewer, executive vice president and CFO, and Doug Lawson, executive vice president of corporate marketing and strategy, will attend the event. Axcelis is scheduled to present on Wednesday, January 11th at 10:40 a.m. Eastern Standard Time. Management will be also available for one on one meetings. A live webcast of Axcelis' presentation will be available to the public and can be accessed from the Investors' section of Axcelis' website at www.axcelis.com, or by accessing the webcast link at http://wsw.com/webcast/needham79/aclshttp://wsw.com/webcast/needham69/acls. A replay of the webcast will be available for 30 days following the presentation.
About Axcelis:Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 35 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.
CONTACTS:Maureen Hart (editorial/media) 978.787.4266 Doug Lawson (investor relations) 978.787.9552
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/axcelis-announces-participation-at-19th-annual-needham-growth-conference-300377072.html
SOURCE Axcelis Technologies, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ruins highlight efforts to trace, preserve roots
- New clinical data on the Leqembi® subcutaneous autoinjector presented at AAIC® 2026 support similar efficacy and safety to IV formulation in early Alzheimer's disease
- MyFlyYatra Is Expanding Its Business Class Flight Travel to Australia, Africa, Japan, Europe, Dubai by Introducing Enhanced Coverage for Global Destinations as Part of Its Ongoing Growth Strategy
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share